Recently, the first NaV1.6 gain-of-function mutation associated with a human neuropathic pain disorder, trigeminal neuralgia, was reported27, highlighting the need to further investigate the role of NaV1.6 in the pain pathway. This evidence concerns the gene SCN8A and trigeminal nerve disorder.